Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00872_DB06697_nanopub.RATkS7geC122C9wtm72prvwnsnJ3warZV045VUTbx25vw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00872_DB06697 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00872_DB06697 label "DDI between Conivaptan and Artemether - Conivaptan, a strong CYP3A inhibitor, may increase the toxicity of artemether by inhibiting its metabolism. Consider alternate therapy or allow at least 7 days to elapse between conivaptan and artemether therapy. [drugbank_resource:DB00872_DB06697]" assertion.
- drugbank_resource:DB00872_DB06697 identifier "drugbank_resource:DB00872_DB06697" assertion.
- drugbank_resource:DB00872_DB06697 title "DDI between Conivaptan and Artemether - Conivaptan, a strong CYP3A inhibitor, may increase the toxicity of artemether by inhibiting its metabolism. Consider alternate therapy or allow at least 7 days to elapse between conivaptan and artemether therapy." assertion.
- drugbank:DB06697 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB06697 assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB06697 assertion.